Severe primary cutaneous Cryptococcus gattii causing ulcerative cellulitis in an immunocompetent patient

Lancet Infect Dis. 2019 Oct;19(10):1148. doi: 10.1016/S1473-3099(19)30409-8.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Administration, Intravenous
  • Administration, Oral
  • Aged
  • Amphotericin B / administration & dosage
  • Amphotericin B / therapeutic use
  • Antifungal Agents / administration & dosage
  • Antifungal Agents / therapeutic use
  • Antigens, Fungal / blood
  • Cellulitis / diagnosis*
  • Cellulitis / drug therapy
  • Cellulitis / immunology
  • Cellulitis / microbiology*
  • Cryptococcosis / diagnosis*
  • Cryptococcosis / drug therapy
  • Cryptococcosis / immunology
  • Cryptococcosis / microbiology
  • Cryptococcus gattii / immunology*
  • Cryptococcus gattii / isolation & purification
  • Debridement
  • Fluconazole / administration & dosage
  • Fluconazole / therapeutic use
  • Humans
  • Immunocompromised Host*
  • Male
  • Treatment Outcome

Substances

  • Antifungal Agents
  • Antigens, Fungal
  • liposomal amphotericin B
  • Amphotericin B
  • Fluconazole